EUCTR2008-005659-83-NL进行中（未招募）不适用
Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial) - SID-GBS trial
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •diagnosed with GBS according to the international accepted criteria, given informed consent, patient in grade 3, 4 or 5 of the GBS disability scale or is there otherwise an indication for IVIg therapy according to the treating neurologist, less than two weeks since onset of weakness, able to attend follow-up of 6 months.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •age below 6 years, severe allergic reaction to properly matched blood products, known to have severe concurrent disease, having selective IgA deficiency, clinical evidence of polyneuropathy caused by other cause than GBS, received immune suppressive therapy during last month, pregnant or breast feeding.
研究者
相似试验
已完成
不适用
Second IVIg Dose in GBS patients with poor prognosis (SID-GBS trial)acute inflammatory demyelinating polyneuropathy (AIDP)Guillain-Barre syndrome1000381610034606NL-OMON47229Erasmus MC, Universitair Medisch Centrum Rotterdam339
已完成
不适用
Second IVIg Dose in Guillain-Barre syndrome patients with poor prognosis.NL-OMON22921Erasmus MC Rotterdam176
已完成
不适用
Trial of the efficacy of a second dose of BCG vaccination against tuberculosis (Avaliação da eficácia da segunda dose da vacina BCG em escolares)Tuberculosis and leprosyInfections and InfestationsTuberculosis, leprosy [Hansen disease]ISRCTN07601391Institute for Collective Health (Instituto de Saúde Coletiva) (Brazil)351,951
进行中（未招募）
1 期
A study of SGI-110 in people with Myelodysplastic syndrome high and Int-2, acute myeloid leukemia = 30% marrow blasts and chronic monocytic leukemia (CMML) type 2Myelodysplastic syndrome high and Int-2, acute myeloid leukemia = 30% marrow blasts and chronic monocytic leukemia (CMML) type 2MedDRA version: 16.1Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2014-000098-38-FRGroupe Francophone des Myélodysplasies (GFM)54
已完成
4 期
International Second Immunoglobulin Dose in Guillain-Barre Syndrome patients with poor prognosis.acute inflammatory demyelinating polyneuropathy (AIDP)Guillain-Barre syndrome1000381610034606NL-OMON35287Erasmus MC, Universitair Medisch Centrum Rotterdam15